Lista de obras - Alessandro Testori - Dominio Público Uruguay

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

artículo científico

Adjuvant Therapy for Melanoma: Past, Current, and Future Developments

scientific article published on 21 July 2020

Adjuvant Treatment of Melanoma: Recent Developments and Future Perspectives

scientific article published on 01 December 2019

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

scientific article published on 07 August 2019

Alternatives for the treatment of local advanced disease: electrochemotherapy, limb perfusion, limb infusion, intralesional IL2. What is the role?

artículo científico publicado en 2012

Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).

artículo científico publicado en 2013

Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings.

artículo científico publicado en 2008

Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters

artículo científico publicado el 1 de junio de 1992

BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer

artículo científico publicado en 2016

Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study).

artículo científico publicado en 2009

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

artículo científico publicado en 2013

Clinical genetic testing for familial melanoma in Italy: A cooperative study

article

Combined approach for the biomechanical characterization of skin lesions

artículo científico publicado en 2015

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

artículo científico publicado en 2017

Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.

artículo científico publicado en 2015

Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases.

artículo científico publicado en 2007

Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.

artículo científico

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.

artículo científico publicado en 2015

Diagnosis and treatment of in-transit melanoma metastases.

artículo científico publicado en 2016

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

artículo científico publicado en 2015

Diagnosis of melanoma in the elderly and surgical implications.

artículo científico publicado en 2004

Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma.

artículo científico publicado en 2013

Diagnostic services for melanoma in Italy.

artículo científico publicado en 2013

EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

artículo científico publicado en 2015

EANM-EORTC general recommendations for sentinel node diagnostics in melanoma

artículo científico publicado en 2009

Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).

artículo científico publicado en 2012

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

artículo científico publicado en 2013

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

artículo científico publicado en 2014

Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial

artículo científico publicado en 2017

Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib

artículo científico publicado en 2017

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study

artículo científico publicado en 2015

Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial

artículo científico publicado en 2015

Follow-up of melanoma: a survey of Italian hospitals.

artículo científico publicado en 2013

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

artículo científico publicado en 2016

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

artículo científico publicado en 2014

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

artículo científico publicado en 2015

Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.

artículo científico publicado en 2016

Heat shock proteins and their use as anticancer vaccines.

artículo científico publicado en 2004

Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.

artículo científico

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

artículo científico publicado en 2014

Impact of mole mapping in the Italian health system

artículo científico publicado en 2013

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

artículo científico publicado en 2011

In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.

artículo científico publicado en 2016

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

artículo científico publicado en 2011

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

artículo científico publicado en 2014

Learning from mistakes: errors in approaches to melanoma and the urgent need for updated national guidelines

artículo científico publicado en 2015

Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensi

artículo científico publicado en 2016

Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma

artículo científico publicado en 2007

Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma

artículo científico publicado en 2012

Lymph node ratio as a prognostic factor in melanoma: results from European Organization for Research and Treatment of Cancer 18871, 18952, and 18991 studies

artículo científico publicado en 2018

Lymphoscintigraphy in clinical routine practice: reproducibility and accuracy in melanoma patients with a long-term follow-up.

artículo científico publicado en 2013

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article published on 13 June 2018

Management of small and intermediate congenital nevi: a nationwide survey in Italy.

artículo científico publicado en 2013

Maspin expression and melanoma progression: a matter of sub-cellular localization.

artículo científico publicado en 2013

Melanoma ??? what is new in sentinel node biopsy and locoregional treatments in 2003? Report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003

article

Melanoma Task Force (META) Project in Italy: methodology.

artículo científico publicado en 2013

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.

artículo científico publicado en 2016

Oncophage: step to the future for vaccine therapy in melanoma

artículo científico publicado en 2008

Pediatric melanoma: analysis of an international registry

artículo científico publicado en 2013

Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.

artículo científico publicado en 2015

Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.

artículo científico publicado en 2008

Pregnancy and melanoma: a European-wide survey to assess current management and a critical literature overview.

artículo científico publicado en 2016

Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.

artículo científico publicado en 2016

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors ⬇️

artículo científico publicado el 19 de agosto de 1991

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).

artículo científico publicado en 2016

Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk

artículo científico publicado en 2005

Report from the Melanoma Independent Board First Melanoma MIB Conference, 21-22 October 2013.

artículo científico publicado en 2014

Report from the second MIB (Melanoma Independent Board) Conference, 27-28 October 2014

artículo científico publicado en 2015

Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy.

artículo científico publicado en 2016

Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.

artículo científico publicado en 2018

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

artículo científico publicado en 2014

Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?

artículo científico publicado en 2012

Sentinel Node Biopsy in Thin and Thick Melanoma

artículo científico publicado en 2013

Sentinel node biopsy for high-risk cutaneous nonanogenital squamous cell carcinoma: a preliminary result.

artículo científico publicado en 2010

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program

artículo científico publicado en 2014

Sunny holidays before and after melanoma diagnosis are respectively associated with lower Breslow thickness and lower relapse rates in Italy

artículo científico publicado en 2013

Surgery and radiotherapy in the treatment of cutaneous melanoma

artículo científico publicado en 2009

Surgery for Metastatic Melanoma: an Evolving Concept

scientific article published on 06 November 2019

Surgical management of suspicious melanocytic lesions in Italy

artículo científico publicado en 2013

Surgical treatment of melanoma: a survey of Italian hospitals.

artículo científico publicado en 2013

The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.

artículo científico publicado en 2017

The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018.

artículo científico publicado en 2019

The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.

artículo científico publicado en 2011

The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.

artículo científico publicado en 2016

The risk of developing a second primary cancer in melanoma patients: a comprehensive review of the literature and meta-analysis.

artículo científico publicado en 2014

The role of BRAF V600 mutation in melanoma

artículo científico publicado en 2012

The role of ultrasound of sentinel nodes in the pre- and post-operative evaluation of stage I melanoma patients

artículo científico publicado en 2005

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study

artículo científico publicado en 2014

Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.

artículo científico publicado en 2017

Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors

artículo científico publicado en 2016

Treatment of metastatic melanoma with electrochemotherapy

artículo científico

Tuning of a deformable image registration procedure for skin component mechanical properties assessment.

artículo científico publicado en 2015

Unknown Primary Melanoma: Worldwide Survey on Clinical Management.

artículo científico publicado en 2017

Update: current management issues in malignant melanoma.

artículo científico publicado en 2005

Utility of adjuvant systemic therapy in melanoma.

artículo científico publicado en 2009

What is new in melanoma research? Vaccines, Basic and Translational Research in 2003: report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003

scientific article published on 01 August 2004

Lista de obras de Alessandro Testori

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

Adjuvant Therapy for Melanoma: Past, Current, and Future Developments

Adjuvant Treatment of Melanoma: Recent Developments and Future Perspectives

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

Alternatives for the treatment of local advanced disease: electrochemotherapy, limb perfusion, limb infusion, intralesional IL2. What is the role?

Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).

Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings.

Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters

BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer

Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study).

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

Clinical genetic testing for familial melanoma in Italy: A cooperative study

Combined approach for the biomechanical characterization of skin lesions

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.

Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases.

Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.

Diagnosis and treatment of in-transit melanoma metastases.

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

Diagnosis of melanoma in the elderly and surgical implications.

Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma.

Diagnostic services for melanoma in Italy.

EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

EANM-EORTC general recommendations for sentinel node diagnostics in melanoma

Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial

Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study

Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial

Follow-up of melanoma: a survey of Italian hospitals.

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.

Heat shock proteins and their use as anticancer vaccines.

Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Impact of mole mapping in the Italian health system

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

Learning from mistakes: errors in approaches to melanoma and the urgent need for updated national guidelines

Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensi

Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma

Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma

Lymph node ratio as a prognostic factor in melanoma: results from European Organization for Research and Treatment of Cancer 18871, 18952, and 18991 studies

Lymphoscintigraphy in clinical routine practice: reproducibility and accuracy in melanoma patients with a long-term follow-up.

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

Management of small and intermediate congenital nevi: a nationwide survey in Italy.

Maspin expression and melanoma progression: a matter of sub-cellular localization.

Melanoma ??? what is new in sentinel node biopsy and locoregional treatments in 2003? Report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003

Melanoma Task Force (META) Project in Italy: methodology.

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.

Oncophage: step to the future for vaccine therapy in melanoma

Pediatric melanoma: analysis of an international registry

Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.

Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.

Pregnancy and melanoma: a European-wide survey to assess current management and a critical literature overview.

Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors ⬇️

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).

Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk

Report from the Melanoma Independent Board First Melanoma MIB Conference, 21-22 October 2013.

Report from the second MIB (Melanoma Independent Board) Conference, 27-28 October 2014

Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy.

Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?

Sentinel Node Biopsy in Thin and Thick Melanoma

Sentinel node biopsy for high-risk cutaneous nonanogenital squamous cell carcinoma: a preliminary result.

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program

Sunny holidays before and after melanoma diagnosis are respectively associated with lower Breslow thickness and lower relapse rates in Italy

Surgery and radiotherapy in the treatment of cutaneous melanoma

Surgery for Metastatic Melanoma: an Evolving Concept